G&M Platform
Diagnosis of rare genetic diseases and hereditary cancers
CommercialActive
Key Facts
Indication
Diagnosis of rare genetic diseases and hereditary cancers
Phase
Commercial
Status
Active
Company
About PhiTech Bioinformatics
PhiTech Bioinformatics is a private, early-stage diagnostics company leveraging artificial intelligence to analyze combined genomic and transcriptomic data. Its core offering is the G&M platform, which aims to significantly improve diagnostic yield for complex genetic conditions, addressing critical unmet needs in the rare disease and hereditary cancer markets. Founded in 2019, the company has raised a seed round, completed a prominent accelerator program, and is targeting diagnostic labs, hospitals, and biopharma partners as its primary customers.
View full company profile